FORCHRONIC

[et_pb_section fb_built=”1″ _builder_version=”3.25.3″][et_pb_row _builder_version=”3.25.3″][et_pb_column type=”4_4″ _builder_version=”3.25.3″][et_pb_text _builder_version=”3.25.3″]This article is created by Lamia Mouhid,Marta Corzo-Martínez, Carlos Torres, Luis Vázquez, Guillermo Reglero, Tiziana Fornari yAna Ramírez de Molina in 2017 May.

Abstract
Cancer is among the leading causes of morbidity and mortality worldwide. Many of the chemotherapeutic agents used in cancer treatment exhibit cell toxicity and display teratogenic effect on nontumor cells. Therefore, the search for alternative compounds which are effective against tumor cells but reduce toxicity against nontumor ones is of great importance in the progress or development of cancer treatments. In this sense, scientific knowledge about relevant aspects of nutrition intimately involved in the development and progression of cancer progresses rapidly. Phytochemicals, considered as bioactive ingredients present in plant products, have shown promising effects as potential therapeutic/preventive agents on cancer in several in vitro and in vivo assays. However, despite their bioactive properties, phytochemicals are still not commonly used in clinical practice due to several reasons, mainly attributed to their poor bioavailability. In this sense, new formulation strategies are proposed as carriers to improve their bioefficacy, highlighting the use of lipid-based delivery systems. Here, we review the potential antitumoral activity of the bioactive compounds derived from plants and the current studies carried out in animal and human models. Furthermore, their association with lipids as a formulation strategy to enhance their efficacy in vivo is also reported. The development of high effective bioactive supplements for cancer treatment based on the improvement of their bioavailability goes through this association. ( … )

 

 [/et_pb_text][et_pb_button button_url=”https://www.ncbi.nlm.nih.gov/pubmed/28555156″ button_text=”Go to article” _builder_version=”3.25.3″][/et_pb_button][/et_pb_column][/et_pb_row][/et_pb_section]

Leave a Reply

Your email address will not be published.

[et_pb_section fb_built=”1″ _builder_version=”3.25.3″][et_pb_row _builder_version=”3.25.3″][et_pb_column type=”4_4″ _builder_version=”3.25.3″][et_pb_text _builder_version=”3.25.3″]

Artículo creado por Lamia Mouhid,Marta Corzo-Martínez, Carlos Torres, Luis Vázquez, Guillermo Reglero, Tiziana Fornari yAna Ramírez de Molina en mayo de 2017.

Abstract
Cancer is among the leading causes of morbidity and mortality worldwide. Many of the chemotherapeutic agents used in cancer treatment exhibit cell toxicity and display teratogenic effect on nontumor cells. Therefore, the search for alternative compounds which are effective against tumor cells but reduce toxicity against nontumor ones is of great importance in the progress or development of cancer treatments. In this sense, scientific knowledge about relevant aspects of nutrition intimately involved in the development and progression of cancer progresses rapidly. Phytochemicals, considered as bioactive ingredients present in plant products, have shown promising effects as potential therapeutic/preventive agents on cancer in several in vitro and in vivo assays. However, despite their bioactive properties, phytochemicals are still not commonly used in clinical practice due to several reasons, mainly attributed to their poor bioavailability. In this sense, new formulation strategies are proposed as carriers to improve their bioefficacy, highlighting the use of lipid-based delivery systems. Here, we review the potential antitumoral activity of the bioactive compounds derived from plants and the current studies carried out in animal and human models. Furthermore, their association with lipids as a formulation strategy to enhance their efficacy in vivo is also reported. The development of high effective bioactive supplements for cancer treatment based on the improvement of their bioavailability goes through this association. ( … )

 

 

[/et_pb_text][et_pb_button button_text=”Ir al artículo” _builder_version=”3.25.3″ button_url=”https://www.ncbi.nlm.nih.gov/pubmed/28555156″][/et_pb_button][/et_pb_column][/et_pb_row][/et_pb_section]

Leave a Reply

Your email address will not be published.